Arcus Biosciences Cash Flow Statement
NYSE: RCUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
24.41+0.58 (+2.43%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Arcus Biosciences free cash flow
In fiscal 2025, Arcus Biosciences generated -$482.0 million of operating cash flow and spent $2.0 million on capital expenditures. That left free cash flow of -$484.0 million, a free-cash-flow margin of -196.0% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Arcus Biosciences cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -353.00M | -283.00M | -307.00M | -267.00M | 53.00M | -123.00M | -84.71M | -49.59M | -53.08M | -17.97M |
| Net Income growth (YoY) | — | — | — | -603.77% | — | — | — | — | — | — |
| Depreciation & Amortization | 10.00M | 10.00M | 8.00M | 6.00M | 4.00M | 3.00M | 3.58M | 3.66M | 2.61M | 1.31M |
| Stock-Based Compensation | 60.00M | 76.00M | 73.00M | 65.00M | 55.00M | 22.00M | 8.98M | 3.87M | 495.00K | 90.00K |
| Change in Working Capital | -216.00M | -53.00M | -69.00M | -104.00M | -378.94M | 196.16M | 1.24M | 1.90M | 24.15M | 3.77M |
| Operating Cash Flow | -482.00M | -170.00M | -306.00M | 438.00M | -256.00M | 111.00M | -73.46M | -43.00M | -25.06M | -12.94M |
| Capital Expenditures | -2.00M | -6.00M | -24.00M | -6.00M | -26.00M | -3.00M | -1.93M | -3.74M | -5.51M | -4.10M |
| Investing Cash Flow | 66.00M | -84.00M | 194.00M | -413.00M | -4.00M | -434.00M | 59.21M | -113.44M | -49.07M | -38.86M |
| Share Repurchases | — | — | — | — | — | — | -94.00K | 0 | — | — |
| Debt Issued | 49.00M | 47.00M | 0 | 0 | — | — | — | — | — | — |
| Financing Cash Flow | 488.00M | 277.00M | 33.00M | 33.00M | 237.00M | 439.00M | 1.12M | 129.07M | 107.40M | 70.10M |
| Net Change in Cash | 72.00M | 23.00M | -79.00M | 58.00M | -23.00M | 116.00M | -13.13M | -27.36M | 33.27M | 18.30M |
| Free Cash Flow | -484.00M | -176.00M | -330.00M | 432.00M | -282.00M | 108.00M | -75.39M | -46.74M | -30.57M | -17.04M |
This table shows 10 annual periods of Arcus Biosciences's cash flow statement, from FY 2025 back to FY 2016, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow RCUS's reporting calendar. What is a cash flow statement?